Company intelligence / Profile preview

PHARMetrics

Watertown, Massachusetts, USA

Ownership: Private
Development stage: Other

Overview

PharMetrics was a leading provider of patient-centric healthcare data and analytical solutions for the pharmaceutical and biotechnology industries. The company specialized in longitudinal medical and pharmaceutical claims data, maintaining a massive database that tracked patient journeys across various care settings. This data was instrumental for health economics and outcomes research (HEOR), market access strategies, and commercial analytics. In 2005, PharMetrics was acquired by IMS Health (now IQVIA) for approximately $102 million. Its core data assets were integrated into IQVIA's offerings and continue to be marketed as the IQVIA PharMetrics Plus database.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on PHARMetrics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PHARMetrics.

Explore the full profile